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1. Introduction
The identification of genes is an ongoing research issue in the biomedical and bioinformatics
community. The Human Genome Project which was completed in 2003, identified
approximately 20,000+ genes in the human DNA, but there are still many of these genes
for which their function or role is unknown, and this accounts only for healthy DNA.
Genetic diseases like Cancer, Alzheimer, Hemophilia and others, have mechanisms that we
currently just started to understand. For instance, genes BRCA1 and BRCA2, famous for
their role in breast cancer (Friedman et al., 1994), only account for 5% of the incidence of the
aforementioned cancer (Oldenburg et al., 2007). Many questions rise: What are the rest of
the mechanisms involved in this cancer type? Are there other genes involved? How? This
only accounts for one type of cancer, and there are at least 177 different types according to
the National Cancer Institute 1. The straightforward method to deal with this problem is
to do wet lab experiments with large samples of normal and disease tissue, to test under
different conditions the reactions, and check the expression or lack of it in different genes.
The complication with this method is the cost, it takes time, it requires specialized equipment,
and thus the economic price tag is high. Fortunately the bioinformatics area has acquired
maturity during the recent years, biological data is becoming available in different formats
throughout different databases and publications are providing new insights. Thanks to these,
computational methods can be developed, methods that would save time, effort and money,
methods that could help biomedical researchers get clues on which genes to explore on the
wet laboratory, so that time is not wasted on genes that are unlikely to contribute in a given
disease.
Gene Prioritization methods can be used to find genes that were previously unknown to be
related to a given disease. The general definition of gene prioritization is: Given a disease D, a
candidate gene set C, and the training data T, then input all these data to the method and it will
compute a score for each of the candidate genes, higher scoring genes are supposed to be the
genes that are most likely related to disease D, see fig. 1. Methods can be classified according
to the type of input data that the method uses, as Text and Data MiningMethods and Network
Based Methods. Text and Data Mining methods use training data like genetic localisation,
gene expression, phenotypic data (van Driel et al., 2003), PubMeb abstracts (Tiffin et al., 2005),
spatial gene expression profiles, linkage analysis (Piro et al., 2010), gene ontology and others
(Adie et al., 2005; Ashburner et al., 2000; Schlicker et al., 2010); as the name suggests this
1 http://www.cancer.gov/cancertopics/alphalist
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methods mine the genome or mine the available biomedical literature to produce the scores
of the candidate genes. Network Based Methods, use biological networks (Chen et al., 2009;
Morrison et al., 2005) as the back bone of the prioritization method, however, some network
based methods also combine some data and text mining techniques to improve their results
(Aerts et al., 2006; Hutz et al., 2008).
The purpose of this chapter is to give an introduction into the Gene Prioritization Problem.
Following the introduction a section explaining Biological Networks is presented as this is
necessary background to understand the network based prioritization methods. After this
section, we discuss about current state of the art prioritization methods with emphasis in
network based methods. Next sections discuss our own prioritization method that is a
network based method with a novel microarray data integration. A discussion on Challenges
and Future Research opportunities follows and finally the conclusions of this chapter along
with a list of available resources for Gene Prioritization.
Fig. 1. General Gene Prioritization Overview
2. Biological networks
2.1 Graph theory background
A graph is a data structure that represents a set of relationships between elements or objects.
Formally a graph G is a pair defined by G = (V, E), where V is a set of elements that
represent the nodes or vertices of the graph, the vertices in most applications hold the
name of the attribute being represented. E is the set of edges, where each edge represent
a relation between two vertices, an edge is defined by E = {(u, v)|u, v ∈ V}, this edges
may hold additional information as weight, confidence or distance between nodes, therefore
having E = {(u, v,w)|u, v ∈ V and w ∈ Re}. The edges may represent direction, where
(u, v) = (v, u), in which case the graph is called directed graph, and when direction is not
important, the graph is called undirected graph.
Graph Properties
Among the intrinsic properties of a graph we have: Nodes, the number of nodes in the
network, formally n = |V|. Edges, the number of edges in the graph, formally e = |E|.
Connectivity is a property of the graph, it is defined to be connectivity(G) = eN where
N = (n2) is the maximum number of possible edges the graph can have. A graph with
connectivity values closer to one would be called dense, and if the connectivity value is close
to zero the graph would be called sparse, it is worth mentioning that there is no agreed
exact value to consider a graph sparse or dense among the graph theory community. The
120 Selected Works in Bioinformati s
www.intechopen.com
Disease Gene Prioritization 3
diameter of a graph is the distance of the longest shortest path on the graph. Graph Path, is
a sequence of vertices of the form {v1, v2, v3, ..., vk} where v1 is the starting node and vk is the
destination node, and (vi, vi+1) ∈ E; the length of the path is defined by l = ∑
k−1
i=1 wi where
wi ∈ (vi, vi+1,wi), when all weights are equal to 1 then the length of the path is k − 1. A
shortest path from vertex v to u is one of the paths that has the least accumulated weight from
u to v, note that there can be multiple shortest paths from one node to another.
Nodes Properties
The most basic node property is the degree that denotes the number of connections a node
has; in directed graphs there can be a distinction between incoming and outgoing connections,
called in-degree and out-degree respectively. Several measures of centrality have been created
to represent how “central” a node with respect to the other nodes in the graph, this measures
are: Closeness Centrality, based in the average shortest path to the other vertices in the
network; Betweenness Centrality, based on the occurrence of the vertex in the shortest paths
of the network, Eigenvalue Centrality, based in the eigenvector of the adjacency matrix that
represents the graph (Freeman, 1979).
2.2 Biological networks overview
In this section a brief background on biological networks is presented. As it was explained
in the previous section, a graph, or network, is a set of relationship between objects, in
the specific case of biological networks those objects are related to biological processes.
Typical biological networks include: gene regulation networks, signal transduction networks,
metabolic networks and protein interaction networks (PIN) (Junker & Schreiber, 2008). Gene
regulation networks, also known as signal transcriptional regulation networks, represent
how genes control the expression of other genes; these networks are often represented by
directed graphs. Signal transduction networks are an extension of gene regulation networks
that represents the links between intracellular processes to extracellular functions in response
to diverse external events and stimuli. The final target in a signal transduction pathway
is either a transcription factor or a metabolic enzyme. Metabolic networks are determined
through biochemical experiments, and consist in metabolites converting into each other with
the interaction of enzymes. The last of the typical biological networks are the PINs, they
represent the interaction between different gene products, they are usually modeled with
undirected networks, indicating only that there is a probable functional relation between the
two related proteins without indicating direction. Some other networks exist that represent
specific problem oriented networks, like (Yeh et al., 2009) that identifies genetic regulatory
network in prostate cancer using microarray data. Fig. 2 and Fig. 3 show the general structure
of a biological network and a sample of a PIN.
2.3 Protein interaction networks
These networks are the central focus of attention in the network based disease gene
prioritization, so they deserve special attention. There are four main approaches to create
PIN: high throughput technology, manual curation from published experiments results,
automatic text mining from published literature and computational prediction from diverse
genomic data (Wu et al., 2008). Some publicly available databases hold high quality, manually
curated PIN, such as HPRD (Prasad et al., 2009), BIND (Bader et al., 2003) and BioGRID
(Breitkreutz et al., 2008), in our workwe have used BioIR (Liu et al., 2009) which integrates the
previously mentioned databases along with DIP (Salwinski et al., 2004), IntAct (Aranda et al.,
2010), MIPS (Pagel et al., 2005) and MINT (Ceol et al., 2010).
121isease Gene Prioritization
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Fig. 2. Structure of a Biological Network
Fig. 3. Sample of Human PIN
2.3.1 Creation and curation of PIN
Current PIN databases are a rich resource of protein interactions, theymostly differ on the way
they acquire their data, or on the way they validate it. For instance HPRD, BIND, BioGRID,
MINT and MIPS are manually curated, this means a team of biologists check the literature
to find new interactions, and once an interaction is confirmed it is added to the database.
On the other hand DIP and IntAct are based on literature mining, they achieve this using
computational methods that retrieve the interaction knowledge automatically from published
papers. Another method to create PIN is using microarray data samples, these methods rely
122 Selected Works in Bioinformati s
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on the principle that co-expressing genes must be related, so by using statistical methods they
can produce the list of likely relationships from the list of gene products in the microarray
data.
2.3.2 Properties of PIN
PIN are known to have the following properties:
• Sparseness, although there is no one preset value of connectivity, it has been showed that
biological networks are sparse containing much less than O(n2) edges in the network. Due
to this property biological networks can be stored more efficiently in memory, and some
algorithms exploit it to improve significantly their time performance.
• Small World, the concept was originated in the social sciences to explain how inside social
networks the path length to go from one node to another is very small. However this is a
subjective measure that lacks statistical or objective measure for actual networks. A more
precise property that is seen in most empirical networks is Power law degree distribution,
where the networks show that some few vertices have high degree and muchmore vertices
have very low degree (Barabasi & Albert, 1999). Recent research has shown that biological
networks do not necessarily follow power law degree distribution, but confirm that the
distribution of degrees is heavy tailed (Garcia De Lomana et al., 2010).
• One of the disadvantageous properties of PIN is that they have a noisy nature, there is a
enormous amount of missing information and false positives in the data (Edwards et al.,
2002), therefore this fact must be taken into consideration when dealing with this kind of
networks.
• As a consequence of the small world property, few nodes have high degree value, and it
has been discovered that these nodes play an important role in the network, as opposed to
other nonessential genes.
• Motifs, deep analysis in PIN has shown that there are recurrent subnetworks appearing in
the full network, these subnetworks are called motifs. They have been discovered using
statistical tools and showing that they occur more in the network than just by random
coincidence (Junker & Schreiber, 2008).
3. Previous and on-going research
As was discussed in the introduction of the chapter prioritization methods can be classified
as text and data mining based and network based methods. The main difference between the
different approaches is the kind of data they use to do the prioritization of the candidate set.
3.1 Text and data mining methods
These methods usually rank candidate genes by matching their information and profile
across multiple biological data sources. GeneSeeker is a web tool that selects candidate
genes of the interest disease based on gene expression and phenotypic data from human
and mouse (van Driel et al., 2003). eVOC system performs candidate gene selection based
on the co-occurrence of disease name in PubMed abstracts through data-mining methods
(Tiffin et al., 2005). DGP (Disease Gene Prediction) (López-Bigas & Ouzounis, 2004) and
PROSPECTS (Adie et al., 2005) use basic sequence information to classify genes as likely or
unlikely to be involved with the disease under study. The extended version of PROSPECTS,
SUSPECTS (Adie et al., 2006), is developed by integrating annotation data from Gene
123isease Gene Prioritization
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Ontology (GO) (Ashburner et al., 2000), InterPro and expression data. However, many of the
methods suffer from limitations imposed by the data source which has little knowledge about
the disease. GO terms include a brief description of the corresponding biological function
of the genes but only 60% of all human genes have associated GO terms and these terms
may be inconsistent due to differences in curators’ judgment (Dolan et al., 2005). Due to
the incomplete data, the approaches reduce the probability to rank the candidate genes of
a specific disease.
Most recent methods of this kind of prioritization include MedSim (Schlicker et al., 2010)
and a method based on spatially mapped gene expression (Piro et al., 2010). MedSim uses
GO enrichment and applies their own similarities measures (Schlicker et al., 2007), by doing
so they manage to extend the existing annotations to achieve the assignment of known
disease genes to the correct phenotypes. The spatially mapped gene expression method
uses a combination of data including linkage analysis, differential expression to acquire the
list of candidates genes, then by using the phenotypes and associated phenotypes they find
reference genes which in turn are filtered with the spatial gene-expression data; then by using
both the candidate genes and the reference genes they apply their method to do the gene
ranking.
3.2 Network based methods
As the name suggests these methods primarily use biological networks to do the prioritization
process, this is mainly due to the increasing availability of human protein interaction data,
and the emergence of network analysis. These methods usually rely on the the assumption
that genes that are associated with diseases have a heavy interaction with each other
(Erten & Koyutürk, 2010). Fig. 4 shows a general overview of these type of methods. The
input that they commonly receive is the set of seed genes S that represent the previous
knowledge to the method, genes that are known to be related to some disease D, along with
these genes a score of how much they are related to the disease is given, denoted by σ(v,D).
The other part of the input is the genome of the organism represented by its PIN, denoted
in the picture as the candidate set C. After the method calculates the score, just like any other
method, it outputs the set of candidate geneswith their score, where higher scores have higher
probability of being related to disease D.
Fig. 4. Network Based Gene Prioritization Methods
Furthermore, network based methods can be classified in local and global methods. Local
methods use local information to the seed genes, basically classifying by network proximity
124 Selected Works in Bioinformati s
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through the inspection of the direct neighbors of the seed genes or higher order neighbors in
other words nodes in the network that are not directly adjacent to the seed nodes but are easily
reached by them. Global methods model the flow through the whole network to provide a
score of the connectivity and impact of the seed genes or previous knowledge on the rest of
the nodes.
Network based gene prioritization is performed by assessing how much genes interact
together and are close to known disease genes in protein networks. Endeavour takes a
machine learning approach by building a model with initial known disease-related genes
as training set, then that model is used to rank the test set of candidate genes according
to the similarity score using multiple genomic data sources(Aerts et al., 2006). Chen et al.
applied link based strategies widely used in social and web network analyses such as HITS
with priors, PageRank, and K-step Markov to prioritize disease candidate genes based on
protein networks (Chen et al., 2009). Ma et al. developed a system for gene prioritization
by Combining Gene expression and protein-protein Interaction network (CGI) using Markov
random field theory (Ma et al., 2007). CANDID used information from publications, protein
domain descriptions, cross-species conservation measures, gene expression profiles and
protein-protein interactions to do a prioritization algorithm on candidate genes that influence
complex human traits (Hutz et al., 2008). GeneRank ranks genes based on Google’s PageRank
algorithm and expression data to do gene prioritization(Morrison et al., 2005). Ozgur et al.
explored the connectivity properties of biological networks to compute an association score
between candidate and disease-related genes (Özgür et al., 2008). Mani et al. proposed
a method called Interactome Dysregulation Enrichment Analysis (IDEA) to predict cancer
related genes using interactome and microarray data (Mani et al., 2008). Karni, Soreq,
and Sharan attempted to predict the causal gene from expression profile data and they
identified a set of disease-related genes that could best explain the expression changes of the
disease-related genes in terms of probable pathways leading from the causal to the affected
genes in the network (Karni et al., 2009).Tables 1 and 2 show a summary of the aforementioned
methods.
4. Gene prioritization from microarray data based on shortest paths GP-MIDAS
In this section we present our current advances in our own method: Gene Prioritization from
MIcroarray DAta on Shortest Paths (GP-MIDAS). Our approach differs from other network
based methods in the way that we assign the weights to the edges of the PIN, by doing so we
manage to get considerable performance compared to other state of the art methods.
4.1 Material
We applied GP-MIDAS for the study of prostate cancer, using the following data sources:
• PIN: Taking advantage of the availability of public protein interaction databases, and
to have a more complete protein-protein interaction network, we integrated PIN data
warehouse includingHPRD, DIP, BIND, IntAct, MIPS, MINT and BioGriddatabases which
has successfully gathered 54,283 available and non-redundant PIN pairs among 10,710
proteins into BioIR database (Liu et al., 2009).
• Microarray Data: We integrated microarray data taken from (Lapointe et al., 2004) that
consists of 72 primary tumors and 41 normal control sample in Stanford Microarray
Database (SMD) (Hubble et al., 2009).
125isease Gene Prioritization
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Method Brief Description
Gene Seeker Gene Expression and Phenotypic Data from Human and Mouse
(van Driel et al., 2003)
eVOC Co-Occurrence of disease name on PubMed abstracts (Tiffin et al.,
2005)
DGP Basic Sequence Information (López-Bigas & Ouzounis, 2004)
PROSPECTS Basic Sequence Information (Adie et al., 2006)
SUSPECTS Extension of PROSPECTS, incorporates GO (Adie et al., 2005;
Ashburner et al., 2000)
MedSim Gene Ontology enrichment with their functional similaritymeasures
(Schlicker et al., 2010)
Spatially Mapped
Expression
3D Gene Expression Data, Expression Profiles, Phenotype data
(Piro et al., 2010)
Limitations Generally imposed by the data source which carries little knowledge
about the disease. For instance GO terms include brief description
of the corresponding biological function of the genes but only 60%
of all human genes have associated GO terms, and they may be
inconsistent due to differences in curators’ judgement (Dolan et al.,
2005).
Table 1. Data and Text Mining Gene Prioritization Methods
• Seed Genes: The initial seed genes known to be related to the prostate cancer are
extracted frompublic OnlineMendelian Inheritance inMan (OMIM) database which stores
gene-disease associations provided by summaries of publications. The list of the seed
genes are shown in Table 3.
• Test Genes: We took the KEGG pathway database (Kanehisa et al., 2004) and PGDB
database (Li et al., 2003) that are manually curated database for prostate cancer and
obtained 102 genes as the truly disease-related genes for prostate cancer. We use this set to
test the accuracy of our method.
4.2 Input preparation
The collected material needs to be prepared to be useful for our method, the details on this
procedure are presented as follows.
4.2.1 Cope with missing values
The microarray dataset consists of N genes and M experiments and can be represented as an
M × N matrix. It presents different gene expression levels Xij | (i ∈ M, j ∈ N) in this matrix.
Gene expressions either over-expressed or under-expressed can be revealed in terms of two
colored channel in the microarray data representing the intensity of the cancer and normal
samples, with values ranging from 0 to 255. The gene expression ratios were calculated as
126 Selected Works in Bioinformati s
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Method Brief Description Data Sources
Endeavor Machine Learning: Using initially known
disease genes; then multiple genomic data
sources to rank (Aerts et al., 2006)
BIND
HITS with Priors Prioritization Based on Networks
using Social and Web Networks
Analysis (Chen et al., 2009)
HPRD, BIND,
BioGRIDPageRank
K-Step Markov
CGI Combination of Protein Interaction
Network and Gene Expression using
Markov Random Field Theory (Ma et al.,
2007)
MIPS, DIP
CANDID Uses Publications, Protein domain
descriptions, cross species conservation
measures, gene expression profiles and
Protein Interaction Networks (Hutz et al.,
2008)
NCBI Conserved Domain
Database
GeneRank Based on Google’s PageRank algorithm,
uses expression data (Morrison et al., 2005)
GO and Synthetic Networks
IDEA Uses the Interactome and Microarray data
(Mani et al., 2008)
B Cell Interactome and
OMIM
CIPHER Based on the assembly of a
Gene-Phenotype Network (Wu et al.,
2008)
HPRD and OMIM
Özgür et al. (2008) Using connectivity properties of the
networks
Literature Mining by GIN
Karni et al. (2009) Verifies expression changes of downstream
genes
HPRD
Limitations Most of these approaches include additional interactions
predicted from co-expression, pathway, functional or
literature data, but still fail to incorporate weights
expressing the confidence on the evidence of the
interactions.
GP-MIDAS Our proposed method, integrates Protein Interaction
Network with Normal and Disease Microarray Data,
using this integration we apply all-pairs shortest paths to
find the significant networks and calculate the score for
the genes.
Table 2. Network Based Gene Prioritization Methods
127isease Gene Prioritization
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Gene ID Gene Symbol Gene name
367 AR Androgen receptor
675 BRCA2 Breast cancer type 2 susceptibility protein
3732 CD82 CD82 antigen
11200 CHEK2 Serine/threonine-protein kinase Chk2
60528 ELAC2 Zinc phosphodiesterase ELAC protein 2
2048 EPHB2 Ephrin type-B receptor 2 precursor
3092 HIP1 Huntingtin-interacting protein 1
1316 KLF6 Krueppel-like factor 6
8379 MAD1L1 Mitotic spindle assembly checkpoint proteinMAD
4481 MSR1 Macrophage scavenger receptor types I and II
4601 MXI1 MAX-interacting protein 1
7834 PCAP Predisposing for prostate cancer
5728 PTEN/ PTENP1 Phosphatidylinositol-3,4,5-trisphosphate
3-phosphatase and dual- specificity protein
phosphatase PTEN
6041 RNASEL 2-5A-dependent ribonuclease
5513 HPC1 Hereditary prostate cancer 1
Table 3. Seed Genes of Prostate Cancer from OMIM Database
the median value of the pixels minus background pixel median value for one color channel
divided by the same for the other channel because the mean value of the normalized ratio is
much easier to be affected by noise than the median value. We applied the base-2 logarithmic
transformation of each gene among experimental dataset and this value carried out the
normalization of the gene expression value with mean 0 and standard deviation 1 in every
experiment. Although microarray can be used to detect thousands of genes under a variety
of conditions, there are still many missing values in microarray (Troyanskaya et al., 2001).
The reasons for missing values include insufficient resolution, image corruption, and dust or
scratches on the slide. If a gene contains many missing values in experiments, it is not easy to
determine a precise expression value for each gene that causes a difficulty in the subsequent
analysis of the regulation networks. However, we can not simply remove all gene data that
contains missing values because the number of remaining genes will become too small to
predict the network correctly. In order to get a better result, the genes that contain less than
20% entries missing in all experiment are picked. In order to get as complete data as possible,
we use the K-Nearest-Neighbors (KNN) algorithm (Troyanskaya et al., 2001) to estimate the
missing values.
4.2.2 Update of microarray expression values
Once the necessary microarray data is collected, we need to preprocess it, so that it becomes
ready to be used in our methods. The preprocessing procedure consists of two steps:
1. Transform the Microarray Data Expression Values. The purpose of this transformation
is to make the expression values ready to be used as weights in the network. This
transformation has two steps, initially the values are updated using a sample of normal
expression microarray data, the effect of this operation is that values that are very
similar between normal and cancer samples should have less impact on our analysis. To
accomplish this we subtract the value from the cancer microarray data to the value of
28 Selected Works in Bioinformati s
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the normal expression data as shown in Equation 1. The next step is to transform the
values, the rationale behind this transformation is that expression values may be negative
for under expressed genes, and if these values are used as they are, our network may have
negative weights, thus making shortest paths analysis more difficult. Equation 2 shows
how the expression values are transformed.
ExpressionValuei = ExpressionValuei − NormalExpresionValuei (1)
Trans f ormedExpresionValuei = − ln
(
| ExpresionValuei | −min
max − min
)
(2)
Considering that the sign of of the value in the microarray data represents over or under
expression, and the fact that we want to make a representation of distance, for this is what
we want in our quantitative analysis, we use the absolute value of the microarray data,
then these results are normalized, using the max and min values found, by doing these two
steps we get values in the range [0, 1], where values closer to 1 mean that they are more
expressed (either over expressed or under expressed). Finally we compute the negative
of the natural logarithm on the previous results, this is to make smaller numbers (less
expression level) become large distances, and bigger numbers (higher expression level)
become short distances. The result of this step is a transformation of the gene expression,
where more expressed genes have smaller value, and less expressed genes have higher
values, in the next step we convert this values into distances between genes, thus more
expressed genes relationships will become shorter distances than less expressed genes
relationships. In the case the ExpresionValuei == min we just set the whole result to
be a big value, since ln(0) is not defined.
2. Convert to Human Protein Interaction Network to a Weighted Network. Since we need
the network to become a weighted one, where these weights are related to the specific
interactions in cancer related network, we use the transformed values of the microarray
data. However the microarray data provides transformed expression values for the genes,
not for the relationship between genes. The Pearson correlation coefficient for analyzing
gene-pair relationships could be unsuitable to explore the true gene relationship because
it is overly sensitive to the shape of an expression curve (Kim et al., 2007).To overcome
this issue, we combine the values of the two interacting genes together. For instance
if we have microarray values {(SEPW1, 4.097), (BRCA1, 1.395), (AKT1, 2.006), (BACH1,
2.823), (AHNAK, 3.597)} and we have the following edges in our graph {(AKT1, AHNAK),
(BACH1, BRCA1), (BRCA1, AKT1)}, then the first edgeweight would be the addition of the
transformed expression values of each of the vertices 2.006 + 3.597 = 5.603 providing the
weight of the first edge. The resulting weighted edges of this instance would be {(AKT1,
AHNAK, 5.603), (BACH1, BRCA1, 4.218), (BRCA1, AKT1, 3.401)}.
4.3 Method description
Our current method is based on the analysis of the shortest paths between all the pairs of the
genes on the input network.
4.3.1 Shortest paths analysis
Genes co-occurring in a particular network tend to participate together in related biological
processes based on their linkage with the known disease genes (Tin et al., 2009). Our
methodology is based in the the computation of all pairs shortest paths (APSP) in the network
129isease Gene Prioritization
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and the retrieval of these paths for posterior analysis in our experiments. The computation
of APSP is carried out using our implementation of the all pairs shortest paths algorithm
(Arias & Soo, 2010), which takes advantage of the topology and special characteristics of
biological networks, such as sparseness and singles, nodes that have only one connection.
We call our implementation KC-APSP. At this step of the process we input our prepared PIN
and get as result a list of all the shortest paths between all the pair combination of the genes.
4.3.2 Scoring of genes on shortest paths
Once all the shortest paths are computed, we traverse the list of shortest paths (PathList),
to verify if any of the seed genes are on the resulting paths, if so, these paths need to be
considered for the scoring. Finally a score is computed for each gene. This analysis is done
across M microarray data experiments.
4.3.3 Compute the score function
Having all the paths stored in PathListm for m ∈ M we can compute the denominator denomm,
to be used in the score function using Equation 3, this is done for each microarray experiment
m.
denomm =
n
∑
i=1
1
lim
(3)
Where lim is the length of the ith path in sample m ∈ M for n generated and filtered by seed set
paths. Once the denominator is ready, we proceed to compute the score. For each experiment
m of M, and for each gene g on the network we compute the score for each gene according to
Equation 4.
Score(Genei,m) =
PathListm
∑
Genei,m∈Pathj,m
1
lj,m
denomm
(4)
The motivation behind Equation 4 is that a gene that appears in more generated paths is going
to achieve higher score, even higher for paths with shorter length, the highest being 1 if the
gene appears in all the found paths.
5. Current results
In this section we present our current results, first we discuss the leave one out cross
validation, and lastly we present the precision and recall of our method compared to other
methods that use similar data sources to GP-MIDAS. As it is shown in this section, ourmethod
presents promising results that can lay the foundation for more advanced and accurate
approaches.
5.1 Leave-one-out cross validation of our method
The performance of our algorithmwas evaluated by leave-one-out cross validationmethod. In
each experimental test on a known-disease gene set S, known as the Seed Set, which contains
|S| genes; we delete one gene g from the Seed Set thus having S′ = S − g. We used S′ set to
train our prioritization model. Then, we prioritized the Candidate Gene Set to determine the
rank of that deleted gene g. We got 100% to cover the deleted genes from the Candidate Gene
Set and the rankness of those seed genes are listed in Table 4; LOO Score Position refers to the
result of GP-MIDAS after deleting the given gene g from the seed set, Closeness Centrality
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Recovered Subnetworks All Seed Genes Subnet.
Gene LOO Score Position Closeness Centrality
Position
Closeness Centrality
Position
AR 1 2 2
PTEN 6 23 24
BRCA2 10 36 26
EPHB2 13 46 42
HIP1 14 43 43
CHEK2 15 35 34
RNASEL 19 53 53
MXI1 20 58 58
MAD1L1 21 53 47
ELAC2 22 61 63
KLF6 26 42 40
MSR1 27 61 62
CD82 33 54 50
Table 4. Leave One Out Experiment Results
on Recovered Network refers to this centrality measure on the induced subgraph made from
the seed set without the given gene g and all the shortest paths generated by this set pairs,
and the last column refers to the centrality measure position on the full network for the given
gene g. In order to realize the performance of gene prioritization with the weighted graph
based on the gene expression, we compare the closeness centrality position in the entire PIN
and sub-networks reconstructed from seed genes. From the entire network and sub-network
of the seed genes using closeness properties, only 1 original seed genes rank among its top 20
ranking genes. However, we recover 8 seed genes among top 20 ranking genes. The results
confirmed that PIN without any gene expression have more false positive and our method
integrated gene expression is potentially able to perform better in the identification of genes
associated with a given disease and should be more informative.
5.2 The precision and recall comparison with previous methods
We evaluated the performance of our algorithm in terms of overall precision versus recall
when varying the rank threshold. Precision is the fraction of true gene-disease associations
that ranked within the top k% in the corresponding trial of the cross validation procedure.
Recall is the fraction of trials in which the disease-related genes from PGDB was recovered
as one of the top k% scoring ones. We compare the performance with the following network
basedmethods: GeneRanker, ENDEAVOUR,HITSwith priors, PageRank, K-stepMarkov and
CIPHER. In GeneRanker, we do not use 543 genes reported to be associated to prostate cancer
in the literature but applied the seed as presented in the list of genes in Table 3. We set a back
probability of 0.3 for PageRankwith priors andHITSwith priors, this value is selected because
(Chen et al., 2009) express that this is the optimal value for back probability, and step size 6
for K-Step Markov method in ToppNet. Further, we reason that the use of literature evidence
in this benchmark test would unfairly improve ENDEAVOUR’s performance because these
literatures may include direct evidence that reports the association between the gene and
the disease. Neither one of these methods rank the seed genes therefore we only compare
the performance with all the genes in the candidate set except the seed genes. Among the
top 10 genes, we got 4 prostate cancer-related genes while applying both normal and cancer
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Precision (%)
Top K 10 20 30 40 50
Methods
HITS with Priors 40 25 23.3 17.5 18
K-Step Markov 20 20 20 22.5 18
PageRank 20 15 20 17.5 18
GeneRanker 30 20 20 20 18
Endeavour 10 15 20 20 20
CIPHER 10 10 10 20 20
GP-MIDAS 40 30 23.3 17.5 20
Table 5. Precision for Top K Rank Comparison Across Methods
Recall (%)
Top K 10 20 30 40 50
Methods
HITS with Priors 4.5 5.6 7.9 7.9 10.1
K-Step Markov 2.2 4.5 6.7 10.1 10.1
PageRank 2.2 3.4 6.7 7.9 10.1
GeneRanker 3.4 4.5 6.7 9 10.1
Endeavour 1 2.9 5.9 7.8 14.6
CIPHER 1.1 2.2 3.4 9.0 11.2
GP-MIDAS 4.5 6.7 7.9 7.9 14.6
Table 6. Recall for Top K Rank Comparison Across Methods
samples and the performance is equal to the HITS with priors which is the highest one from
the previous methods. We also get the highest precision among the top 50 ranking genes.
Tables 5 and 6 denote that ourmethod gets the highest precision and recall. Using the different
expression values between cancer and normal samples may help us to extract more significant
genes and rank them to be higher. Fig. 5 shows the combined precision and recall value using
F-Measure, in the figure can be clearly seen that in most instances GP-MIDAS outperforms
other methods.
6. Challenges and future research opportunities
As it was previously discussed gene prioritizationmethods can be either data and text mining
based or network based, however the division line between these two approaches is less clear
every day as some methods integrate both approaches and use more information to improve
the accuracy of the results. Despite the increase of accuracy, the main challenge is to find
novel genes that are actually involved with a given disease, genes that have not been reported
before, presenting the problem of proving that the newly found genes are in fact involvedwith
the disease. Therefore it becomes essential to present more and better biological explanations
on the definition of newer approaches, by doing so biomedical researchers will have more
confidence in trying the novel genes in in-vitro experiments. One clear research opportunity is
presented, and it is the combination of different network based approaches, by using local and
global information. The work of (Erten & Koyutürk, 2010) shows promising results, aiming
at the discovery of loosely connected genes using statistical correction schemes that help
overcome the preference of straightforward method for genes with high centrality values; this
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Fig. 5. F-Measure of different methods applied to Prostate Cancer
aproach uses only global methods, (Navlakha & Kingsford, 2010) combines several network
based methods to produce a new score which also shows a potential new research line.
7. Conclusions
The past few years have shown an increasing interest in the disease gene prioritization
problem and thanks to the availability of more and better data sources there has been a
growing number of methods and approaches to this problem. A plethora of methods have
become available for the genetics disease research community, and as the methods become
more mature the results will become increasingly accurate and more biologically meaningful.
Our own approach GP-MIDAS has proven to be promising showing a better performance
in most instances to related methods, exposing that by setting the weights of the PIN to have
more relatedmeaning to the given disease the results can be better than previous plain shortest
paths methodologies.
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Resources
In this last section we present online resources, please note that since this is an evolving field,
some of these resources can change with time. For a list of projects hosting biological networks
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see Table 7; these sites have the capability of being queried for specific proteins, or the user
can also download the interaction network that is needed for his particular research. For a
list of sites that offer online diseases information or software tools for disease information see
Table 8. For a list of sites that offer online ontologies or software tools for ontologies see Table
9. And for a list of sites that offer online prioritization or software tools to do prioritization
see Table 10.
Human Protein
Reference Database
HPRD http://www.hprd.org
Biomolecular Interaction
Network Database
BIND http://bond.unleashedinformatics.com
Biological General
Repository for
Interaction Datasets
BioGRID http://thebiogrid.org/
Database of Interacting
Proteins
DIP http://dip.doe-mbi.ucla.edu/
IntAct Molecular
Interaction Database
IntAct http://www.ebi.ac.uk/intact/
The MIPS Mammalian
Protein-Protein
Interaction Database
MIPS http://mips.helmholtz−muenchen.de/proj/ppi/
Molecular Interaction
Database
MINT http://mint.bio.uniroma2.it/mint/
Kyoto Encyclopedia of
Genes and Genomes
KEGG http://www.genome.jp/kegg/
National Center
for Biotechnology
Information
NCBI http://www.ncbi.nlm.nih.gov/
Table 7. Available Biological Networks Sites
Online Mendelian
Inheritance in Man
OMIM http://www.ncbi.nlm.nih.gov/omim
The Human Gene
Compendium
GeneCards http://www.genecards.org/
Genetic Association
Database
GAD http://geneticassociationdb.nih.gov/
Catalog of Published
Genome Wide
Association Studies
GWAS http://www.genome.gov/gwastudies/
Table 8. Available Disease Information Sites
Gene Ontology (The Gene Ontology Consortium, 2008) http://www.geneontology.org/
eVOC Ontology (Kelso et al., 2003) http://www.evocontology.org/
InterPro (Hunter et al., 2009) http://www.ebi.ac.uk/interpro/
Table 9. Available Biological Ontology Sites
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MedSim http://www.funsimmat.de/
Endeavor http://homes.esat.kuleuven.be/ bioiuser/endeavour/index.php
ToppGene http://toppgene.cchmc.org/
Cypher http://rulai.cshl.edu/tools/cipher/
CANDID https://dsgweb.wustl.edu/hutz/candid.html
SUSPECTS http://www.genetics.med.ed.ac.uk/suspects/
GP-MIDAS http://bioir.cs.nthu.edu.tw/bne
Table 10. Available Gene Prioritization Sites
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